Hematology/Oncology

• In the Journals

• Nearly all childhood cancer survivors develop chronic health conditions

• June 18, 2013
• About 98% of childhood cancer survivors evaluated in a long-term study developed at least one serious chronic health condition during adulthood.
  Many of...More »

• Meeting News Coverage Perspective

• Gene mutations common in black women at high risk for breast cancer

• June 14, 2013
• CHICAGO — More than one-fifth of black women with breast cancer who were characterized as being at higher risk for the disease carried an inherited...More »

• Perspective

• Supreme Court rules human genes cannot be patented

• June 13, 2013
• The U.S. Supreme Court has ruled unanimously today that genes and the information they encode are not eligible for patents.
  The case involved patents...More »

• Meeting News Coverage Perspective

• Weekly paclitaxel produced fewer toxicities than biweekly schedule

• June 13, 2013
• CHICAGO — Weekly dosing of paclitaxel and standard biweekly dosing resulted in nearly identical PFS among women with higher-risk early-stage breast...More »

• Meeting News Coverage Perspective

• Radiotherapy showed similar control rates, fewer side effects than dissection

• June 6, 2013
• CHICAGO — Five-year survival outcomes were similar for axillary radiotherapy and axillary lymph node dissection in a cohort of women with primary...More »

• Meeting News Coverage Video

• aTTom: Extended hormonal therapy should be considered for higher risk patients

• June 4, 2013
• HemOnc Today editorial board member Debasish “Debu” Tripathy, MD offers his opinion on the long-term clinical implications of the aTTom trial,...More »

• Meeting News Coverage Video

• ATLAS outcomes confirmed: 10 years of tamoxifen superior to 5 years for prevention of breast cancer recurrence

• June 3, 2013
• CHICAGO – Clifford Hudis, MD, president of ASCO, shares his thoughts on the implications of the aTTom study, presented during the plenary...More »

• Meeting News Coverage Perspective

• Extended tamoxifen reduced breast cancer recurrence, mortality

• June 3, 2013
• CHICAGO —  Women with ER-positive breast cancer who underwent 10 years of adjuvant treatment with tamoxifen were at reduced risk for late...More »

• Meeting News Coverage Video

• Axillary dissection alone, radiation alone, both viable treatments in patients with positive sentinel nodes

• June 3, 2013
• CHICAGO – ASCO President-Elect Clifford Hudis, MD discusses late-breaking data from Rutgers and colleagues’ presentation on those patients...More »

• Cover Stories

• Targeted therapies continue to improve outcomes in HER-2–positive breast cancer

• HemOnc Today, June 10, 2013
• The FDA’s decision in February to approve ado-trastuzumab emtansine for the treatment of HER-2–positive breast cancer has been labeled a...More »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!